[go: up one dir, main page]

AR104676A1 - Composición media para preparar toxina botulínica - Google Patents

Composición media para preparar toxina botulínica

Info

Publication number
AR104676A1
AR104676A1 ARP160101184A ARP160101184A AR104676A1 AR 104676 A1 AR104676 A1 AR 104676A1 AR P160101184 A ARP160101184 A AR P160101184A AR P160101184 A ARP160101184 A AR P160101184A AR 104676 A1 AR104676 A1 AR 104676A1
Authority
AR
Argentina
Prior art keywords
medium
hydrolyzate
botulinum toxin
composition
medium composition
Prior art date
Application number
ARP160101184A
Other languages
English (en)
Inventor
Min Kyoung
Min - Sul Hye
Young - Kim Kyoung-Yun
Original Assignee
Daewoong Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Co Ltd filed Critical Daewoong Co Ltd
Publication of AR104676A1 publication Critical patent/AR104676A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente se refiere a una composición de medio para la producción de toxina botulínica y más específicamente, a una composición de medio para el cultivo de Clostridium sp. capaz de producir toxina botulínica. La composición del medio de la presente comprende un hidrolizado de caseína y al menos una peptona de origen vegetal seleccionada del grupo compuesto por un hidrolizado de guisante de jardín, un hidrolizado de semilla de algodón y un hidrolizado de gluten de trigo. Cuando se utiliza el medio de acuerdo con la presente, que contiene peptonas de origen vegetal, hidrolizados de caseína y minerales para el cultivo de Clostridium botulinum, la tasa de crecimiento de la bacteria en el medio es mayor a la de cada uno de los medios utilizados en ia actualidad y a la del medio que comprende peptonas de origen vegetal solamente. Además, cuando se utiliza el medio de la presente, se puede producir una alta concentración de toxina botulínica mediante el cultivo de la bacteria en una forma segura. Método para producir la toxina botulínica.
ARP160101184A 2015-04-28 2016-04-27 Composición media para preparar toxina botulínica AR104676A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020150059655A KR101729251B1 (ko) 2015-04-28 2015-04-28 보툴리눔 독소의 제조를 위한 배지 조성물

Publications (1)

Publication Number Publication Date
AR104676A1 true AR104676A1 (es) 2017-08-09

Family

ID=57199640

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160101184A AR104676A1 (es) 2015-04-28 2016-04-27 Composición media para preparar toxina botulínica

Country Status (19)

Country Link
US (1) US10117927B2 (es)
EP (1) EP3289070B1 (es)
JP (2) JP2018506262A (es)
KR (1) KR101729251B1 (es)
CN (1) CN107109353B (es)
AR (1) AR104676A1 (es)
AU (1) AU2016253789B2 (es)
CA (1) CA2968044C (es)
DK (1) DK3289070T3 (es)
ES (1) ES2805726T3 (es)
HR (1) HRP20201067T1 (es)
HU (1) HUE050244T2 (es)
MX (1) MX381868B (es)
PL (1) PL3289070T3 (es)
PT (1) PT3289070T (es)
RU (1) RU2689705C2 (es)
SA (1) SA517381722B1 (es)
TW (1) TWI592485B (es)
WO (1) WO2016175566A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101723167B1 (ko) * 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101723168B1 (ko) * 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR102209159B1 (ko) * 2019-03-29 2021-01-29 (주)제테마 독소의 제조방법
KR20250090758A (ko) 2023-12-13 2025-06-20 주식회사 알에프바이오 클로스트리디움 보툴리눔(Clostridium botulinum) 균주의 독소 생산성을 높이는 배지 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB790521A (en) * 1955-11-15 1958-02-12 Bristol Lab Inc Improvements in or relating to antibiotics
CA2336363A1 (en) * 1998-07-03 2000-01-13 Dsm N.V. Fermentation process to produce clavulanic acid at a low concentration of free amino acids
US6558926B1 (en) * 1999-07-16 2003-05-06 Massachusetts Institute Of Technology Method for production of tetanus toxin using media substantially free of animal products
RU2230325C2 (ru) * 2002-08-15 2004-06-10 Научно-исследовательский институт микробиологии Министерства обороны Российской Федерации Способ приготовления очищенного препарата ботулинического токсина типа а
US7160699B2 (en) 2003-09-25 2007-01-09 Allergan, Inc. Media for clostridium bacterium and processes for obtaining a clostridial toxin
US7148041B2 (en) * 2003-09-25 2006-12-12 Allergan, Inc. Animal product free media and processes for obtaining a botulinum toxin
WO2005038009A2 (en) * 2003-10-17 2005-04-28 Ranbaxy Laboratories Limited Production of tacrolimus (fk-506) using new streptomyces species
WO2006042542A2 (en) * 2004-10-19 2006-04-27 Statens Serum Institut Production of tetanus, diphtheria, and pertussis toxins and toxoids using fermentation media containing no components of animal or soy origin
MXPA06009853A (es) * 2005-03-03 2007-03-29 Allergan Inc Medios para bacteria de clostridium y procesos para obtener una toxina clostridial.
FR2918671B1 (fr) * 2007-07-10 2010-10-15 Sanofi Pasteur Milieu de culture d'haemophilus influenzae type b.
CN101698826A (zh) * 2007-12-19 2010-04-28 杨宇 胰酪胨肉毒梭菌增菌肉汤
KR20090120222A (ko) * 2008-05-19 2009-11-24 (주)메디톡스 식물 유래 성분 함유 배지 및 가요성 폐쇄 용기를 이용하여클로스트리디움 보툴리눔 독소를 생산하는 방법
US8236356B2 (en) * 2008-06-11 2012-08-07 Roche Diagnostics Operations, Inc. Growth medium for Clostridium histolyticum
US8129139B2 (en) 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
WO2012125948A1 (en) * 2011-03-16 2012-09-20 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
BR122016023101B1 (pt) * 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
CN103215310B (zh) * 2013-03-27 2015-01-21 中棉紫光生物科技(上海)有限公司 用于发酵的棉籽蛋白及其制备方法和应用
KR101339349B1 (ko) 2013-08-02 2013-12-09 주식회사 대웅 보툴리눔 독소의 제조방법

Also Published As

Publication number Publication date
BR112017012889A2 (pt) 2018-01-30
HRP20201067T1 (hr) 2021-02-05
AU2016253789B2 (en) 2018-12-06
WO2016175566A1 (en) 2016-11-03
SA517381722B1 (ar) 2021-03-07
ES2805726T3 (es) 2021-02-15
AU2016253789A1 (en) 2017-06-01
RU2689705C2 (ru) 2019-05-28
RU2017120813A3 (es) 2018-12-14
CA2968044A1 (en) 2016-11-03
CN107109353B (zh) 2025-10-10
RU2017120813A (ru) 2018-12-14
JP6887467B2 (ja) 2021-06-16
PL3289070T3 (pl) 2020-11-16
KR20160127998A (ko) 2016-11-07
JP2018506262A (ja) 2018-03-08
CA2968044C (en) 2022-08-09
DK3289070T3 (da) 2020-07-27
CN107109353A (zh) 2017-08-29
PT3289070T (pt) 2020-07-16
MX2017008199A (es) 2017-12-04
JP2020072649A (ja) 2020-05-14
HUE050244T2 (hu) 2020-11-30
EP3289070A1 (en) 2018-03-07
TW201638329A (zh) 2016-11-01
US10117927B2 (en) 2018-11-06
MX381868B (es) 2025-03-13
TWI592485B (zh) 2017-07-21
EP3289070A4 (en) 2018-09-26
EP3289070B1 (en) 2020-05-06
US20170252431A1 (en) 2017-09-07
KR101729251B1 (ko) 2017-04-21

Similar Documents

Publication Publication Date Title
MX2021010518A (es) Medios y metodos de fermentacion para producir polisacarido en cultivo celular bacteriano.
AR104419A1 (es) Composición media para preparar toxina botulínica
MX2023009109A (es) Una variante de isopropilmalato sintasa novedosa y un procedimiento de produccion de l-leucina usando la misma.
BR112017021255A2 (pt) microrganismo modificado para a produção otimizada de 2,4-di-hidroxibutirato
AR079187A1 (es) Proceso de fermentacion para la produccion de acido glicolico
AR109564A1 (es) Métodos para producir enterovirus c para la producción de vacunas
MX351974B (es) Cultivo de celulas de mamifero.
AR104676A1 (es) Composición media para preparar toxina botulínica
MX2014008441A (es) Enzimas de clostridium histolyticum y metodos para el uso de los mismos.
AR115301A1 (es) Microorganismo que tiene aumento de productividad de glicina y método para producir una composición fermentada usando el mismo
AR081151A1 (es) Metodo para producir bacterias pertenecientes al genero bifidobacterium
MX2017015668A (es) Microorganismos recombinante para la produccion mejorada de quimicos finos.
BR112014002624A8 (pt) Microorganismo recombinante e cultura de microorganismo recombinante
EA201491785A1 (ru) Способ ферментации
AR083613A1 (es) Proceso para la produccion de acido polilactico usando monascus
BR112016005456A2 (pt) método para produzir um l-aminoácido por um método de fermentação, e, dna isolado
RU2016147962A (ru) Микроорганизм, обладающий улучшенной способностью к продуцированию l-лизина, и способ производства l-лизина с использованием данного микроорганизма
RU2016144211A (ru) Микроорганизм рода Gorynebacterium для продуцирования L-лизина и способ получения L-лизина с его помощью
AR104418A1 (es) Composición media para preparar toxina botulínica
WO2015177641A3 (en) Methods of oil production in microorganisms
MX2018010283A (es) Metodo para producir factor de crecimiento de hepatocitos (hgf) activo.
AR099810A1 (es) Microorganismos que producen aminoácidos l y proceso para producir aminoácidos l utilizándolos
PH12015500459B1 (en) Picornavirus-like particle production in plants
MY173672A (en) Sap preparation method, microorganism culture method, useful substance producing method and sap component utilization method
TH161371A (th) วิธีการเพาะเลี้ยงยีสต์